Simple Summary Despite advances in cancer treatment, difficult-to-treat tumor subtypes
remain a challenge. New multidisciplinary approaches can help overcome current obstacles …

Personalized cancer therapy is likely to be one of the next big advances in our search for a
cure for cancer. To be able to treat people in an individualized manner, researchers need to …

Clinical and histopathologic characteristics of breast cancer have long played an important
role in treatment decision-making. Well-recognized prognostic factors include tumor size …

Breast cancer (BC) is the most common malignancy in women. It is classified into a few
major molecular subtypes according to hormone and growth factor receptor expression …

Breast cancer remains a leading cause of cancer-related mortality in women, reflecting
profound disease heterogeneity, metastasis, and therapeutic resistance. Over the last …

Breast cancer is the most commonly occurring cancer in women. There were over two-
million new cases in world in 2018. It is the second leading cause of death from cancer in …

Breast cancer is a complex disease characterized by many morphological, clinical and
molecular features. For many years, this disease has been classified according to …

Breast carcinomas can be stratified into different entities based on clinical behavior,
histologic features, and/or by biological properties. A classification of breast cancer should …

Breast cancer is the most common malignancy among women. It is frequently treated with
chemotherapy and hormone therapy. More recently, however,'targeted therapy'has emerged …

Remarkable progress in sequencing technology over the past 20 years has made it possible
to comprehensively profile tumors and identify clinically relevant genomic alterations. In …